SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001854270-23-000076
Filing Date
2023-06-21
Accepted
2023-06-21 19:13:48
Documents
1
Period of Report
2023-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1687389217.html 4  
1 FORM 4 wk-form4_1687389217.xml 4 3956
  Complete submission text file 0001854270-23-000076.txt   5581
Mailing Address C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address
Collins James J. (Reporting) CIK: 0001779269 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40440 | Film No.: 231031188

Mailing Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address 2 CORPORATE DRIVE, FIRST FLOOR SOUTH SAN FRANCISCO CA 94080 (650) 382-3281
Senti Biosciences, Inc. (Issuer) CIK: 0001854270 (see all company filings)

IRS No.: 862437900 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)